Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Nivalis Therapeutics Announces FDA Orphan Drug Designation for N91115 in Cystic Fibrosis
Nivalis Therapeutics, Inc., a clinical stage pharmaceutical company focused on developing innovative solutions for people with cystic fibrosis (“CF”), announced the U.S. Food and Drug Administration ("FDA") has granted Orphan Drug Designation to the Company's lead investigational drug, N91115, a novel stabilizer of the cystic fibrosis transmembrane conductance regulator (CFTR) protein.
- Read more about Gilead submits NDA to FDA for Chronic Hepatitis B drug
Gilead Sciences, Inc. announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tenofovir alafenamide (TAF) 25 mg, an investigational, once-daily treatment for adults with chronic hepatitis B virus (HBV) infection.
- Read more about Volpara Solutions Receives FDA Clearance for Volpara Density Maps
Volpara Solutions, the leading provider of automated breast density assessment and quantitative breast imaging tools, announced that it has received a new 510(k) clearance from the U.S. Food & Drug Administration (FDA) for Volpara Density Maps, a new solution designed to help radiologists address the requirement in the BI-RADS 5th Edition Atlas to provide “an overall assessment of the volume of attenuating tissues in the breast, to help indicate the relative possibility that a lesion could be obscured.”

[adsense:336x280:8701650588]
- Read more about Pluristem Receives U.S. FDA Clearance to Initiate Clinical Trial of PLX-R18
Pluristem Therapeutics Inc, a leading developer of placenta-based cell therapy products, announced that the U.S. Food and Drug Administration (FDA) cleared the Company’s Investigational New Drug (IND) application to begin its Phase I trial of PLX-R18 cells to treat incomplete hematopoietic recovery following Hematopoietic Cell Transplantation (HCT). The clinical trial is expected to begin in the first half of 2016.
- Read more about Diabetes drug slows down growth of pancreatic cancer
Researchers are likely to have uncovered a novel mechanism behind the ability of the common diabetes drug - metformin -- to inhibit the progression of pancreatic cancer.
- Read more about Bone marrow lesions can predict joint disease
Bone marrow lesions (BMLs) are likely to help predict a swiftly progressing joint disease, says a study.
- Read more about Anti-cancer drug made more effective to reduce side effects
Researchers have found a way to make an existing drug used to treat breast, lung and pancreatic cancers effective in small dosage, thereby reducing its usage and associated side effects in course of the treatment.
- Read more about Know why obesity ups colorectal cancer risk
The risk of developing colorectal cancer in obese people is about 50 percent greater compared to the risk in lean people, says new research.
- Read more about Obesity linked with blood clots in kids, juveniles
Obesity has an association with the formation of blood clots in the veins of children and adolescents, says a new study.
- Read more about NICED in talks with Bengal to launch cholera vaccine
The National Institute of Cholera and Enteric Diseases (NICED), a premier institute under the Indian Council of Medical Research (ICMR), is in talks with the West Bengal government to introduce a cholera vaccine ahead of the peak season as a preventive measure.